First-In-Patient Procedures with SI-BONE iFuse TORQ TNT
Designed to address the anatomic and biomechanical challenges of pelvic fragility fractures, TNT offers an alternative to traditional cannulated screws. Oct 10, 2024
Smith+Nephew Signs Co-Marketing Agreement with JointVue
JointVue's patented OrthoSonic 3D Surgery Planning Technology is reportedly the only ultrasound device on the market to deliver 3D preoperative planning. Oct 09, 2024
Vy Spine Gains 510(k) for LumiVy OsteoVy PEKK Lumbar IBF
The LumiVy OsteoVy PEKK Lumbar IBF combines osseointegration properties of the 3D-printed OXPEKK material and the novel OsteoVy lattice structure. Oct 09, 2024
Regenity Biosciences Scores 510(k) for RejuvaKnee
RejuvaKnee is a minimally invasive collagen-based meniscal implant indicated for use in the reinforcement and repair of soft tissue injuries. Oct 09, 2024
Foundation Surgical Gains 510(k) for Interwedge Standalone Lateral Interbody
Interwedge is used with LLIF180, the first bilateral-fixated standalone-lateral procedure performed through a single-position lateral or oblique-lateral lumbar spine approach. Oct 07, 2024
Enovis and Ossium Partner for OssiGraft Distribution
The collaboration enables distribution of OssiGraft™ and OssiGraft Prime cryopreserved viable bone matrix allografts through Enovis’ sales network. Oct 04, 2024
Corin Earns 510(k) for Unity Knee MC Tibial Insert
As part of the Unity Knee system, it is compatible with ApolloKnee, Corin's next-generation robotic-assisted surgical platform. Oct 04, 2024
OrthAlign Receives FDA 510(k) Clearance for Lantern Hip
Next-generation accelerometers and gyroscopes offer a streamlined workflow, real-time navigation for cup positioning, and restoration of leg length and offset. Oct 04, 2024
Bioretec Accelerates Development of RemeOs Interbody Cage
The RemeOs Cage is engineered from a multifunctional, MRI-compatible, absorbable hybrid composite based on the company's proprietary magnesium alloy. Oct 04, 2024
Amphix Bio Gains Breakthrough Device Designation
The designation covers use of a drug/device combination product to treat degenerative disc disease with transforaminal lumbar interbody fusion. Oct 03, 2024
